Grant: Fellowship - PA: Respiratory Health - CIHR/CLA/GSK
University of British Columbia
$26,719.00
Susceptibility to severe human respiratory syncytial virus infections during early childhood: the role of the innate immune system.
EF 2010-11
Résumé
Lungs are for life. Unfortunately, the most frequent long-term illnesses in children and babies are conditions of the respiratory system. Damage to the lungs of children can have different genetic, developmental, and environmental causes. Respiratory Syncytial Virus (RSV) infections are very common. RSV is the single most important cause of severe respiratory illness in babies and children under 5 years of age, and there is no RSV vaccine that can protect them from becoming ill. In most cases, RSV infection leads to only mild, cold-like symptoms. Nevertheless, 2% to 3% of previously healthy children that become infected with RSV develop a severe respiratory illness that requires admission to a hospital. Worldwide, this virus claims the lives of an estimated 600,000 to 1 million children every year. In addition, it has been shown that babies who become severely ill from an RSV infection also have a higher chance of developing asthma later in life. The reason why RSV causes a life-threatening illness in some seemingly healthy children, but only a mild disease in most other children is largely unknown. Its association with asthma is also not well understood. My project seeks to answer these critical questions.
My work focuses on how our immune system senses an RSV infection at the molecular level. We predict that subtle variations in one's DNA can alter the fine tuning of our immune response to RSV and allergens that promote asthma. Knowing how common DNA variation promotes severe RSV disease and asthma will help us to identify children at risk before they become ill. Such children may benefit from preventative therapies and live a healthier life. Moreover, by identifying key elements of the immune system triggered by RSV infection, we will begin to find new therapeutic targets and can guide scientists in the development of RSV vaccines.
Programme
Fellowship - PA: Respiratory Health - CIHR/CLA/GSK
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
215948
Name
Marr Nico
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Partnername
GlaxoSmithKline (Mississauga, Ontario); Canadian Lung Association (Ottawa)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Susceptibility to severe human respiratory syncytial virus infections during early childhood: the role of the innate immune system.
Programtype2
Fellowship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$26,719
Cihrequipment2
$0
Programname2
Fellowship - PA: Respiratory Health - CIHR/CLA/GSK
Keyworddelim
Cell And Virus Culture; Cytokine Detection (Multiplex Cytometry-Based Assays; Elisa); Functional Genomics (Human Genome Arrays); Quantitative Rt-Pcr; Sirna-Based Gene Knock-Down; Use Of Pharmacological Inhibitors / Modulators
Abstract
Lungs are for life. Unfortunately, the most frequent long-term illnesses in children and babies are conditions of the respiratory system. Damage to the lungs of children can have different genetic, developmental, and environmental causes. Respiratory Syncytial Virus (RSV) infections are very common. RSV is the single most important cause of severe respiratory illness in babies and children under 5 years of age, and there is no RSV vaccine that can protect them from becoming ill. In most cases, RSV infection leads to only mild, cold-like symptoms. Nevertheless, 2% to 3% of previously healthy children that become infected with RSV develop a severe respiratory illness that requires admission to a hospital. Worldwide, this virus claims the lives of an estimated 600,000 to 1 million children every year. In addition, it has been shown that babies who become severely ill from an RSV infection also have a higher chance of developing asthma later in life. The reason why RSV causes a life-threatening illness in some seemingly healthy children, but only a mild disease in most other children is largely unknown. Its association with asthma is also not well understood. My project seeks to answer these critical questions.
My work focuses on how our immune system senses an RSV infection at the molecular level. We predict that subtle variations in one's DNA can alter the fine tuning of our immune response to RSV and allergens that promote asthma. Knowing how common DNA variation promotes severe RSV disease and asthma will help us to identify children at risk before they become ill. Such children may benefit from preventative therapies and live a healthier life. Moreover, by identifying key elements of the immune system triggered by RSV infection, we will begin to find new therapeutic targets and can guide scientists in the development of RSV vaccines.
Competitiondate
201010
Approvedterm2
1 yr 7 mths
Pinamesdelim
Marr, Nico
Approvedterm
1 an 7 mois
Cihrcontribution2
Patient Oriented Research~ $26,719~ $0~